Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in GALT — Galectin Therapeutics Inc

CIK 1390777 NEW YORK, NY
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$490,642
+$428,635 QoQ
Shares Held
105,742
+108.0% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 98 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. GALT ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in GALT

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $490,642 105,742
2025-03-31 $62,007 50,826
2024-12-31 $65,564 50,826
2024-09-30 $117,481 42,721
2024-06-30 $145,595 64,423
2023-12-31 $38,312 23,080
2023-09-30 $44,312 23,080
2023-06-30 $33,234 23,080
2023-03-31 $48,465 23,079
2022-12-31 $26,079 23,079
2022-09-30 $37,618 23,079
2022-06-30 $30,233 23,079
2022-03-31 $37,157 23,079
2021-12-31 $47,773 23,079
2021-09-30 $89,546 23,079
2021-06-30 $73,855 23,080
2021-03-31 $216,784 99,901
2020-12-31 $240,597 107,410
2020-09-30 $295,757 110,771
2020-06-30 $344,653 112,632
2020-03-31 $224,202 114,390